210
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling

, , , , , , & show all
Pages 223-227 | Received 20 May 2009, Accepted 29 Jun 2009, Published online: 26 Feb 2010

References

  • Kwong LK, Uryu K, Trojanowski JQ, Lee VM-Y. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals. 2008; 16: 41–51
  • Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319: 1668–72
  • Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, van de Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40: 572–4
  • Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008; 7: 409–16
  • Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol. 2008; 63: 538–42
  • Kühnlein P, Sperfeld AD, van Massenhove B, van Deerlin V, Lee VM, Trojanowski JQ, et al. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol. 2008; 65: 1185–9
  • Rutherford, NJ, Zhang, YJ, Baker, M, Gass, JM, Finch, NA, Xu, YF, , et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2009;4; e1000193:1–7.
  • Daoud H, Valdmanis PN, Kabashi E, Dion P, Dupré N, Camu W, et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet. 2009; 46: 112–4
  • Corrado, L, Ratti, A, Gellera, C, Buratti, E, Castellotti, B, Carlomagno, Y, , et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat. 2009, Feb 17. (Epub ahead of print).
  • del Bo, R, Ghezzi, S, Corti, S, Pandolfo, M, Ranieri, M, Santoro, D, , et al. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol. 2009, Feb 19. (Epub ahead of print).
  • Lemmens R, Race V, Hersmus N, Matthijs G, van den Bosch L, van Damme P, et al. TDP-43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2009; 80: 354–5
  • Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem. 2005; 280: 37572–84
  • Gijselinck, I, Sleegers, K, Engelborghs, S, Robberecht, W, Martin, JJ, van den Berghe, R, , et al. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging. 2007, doi:10.1016/j.neurobiolaging.2007.11.002.
  • Rezania K, Yan J, Dellefave L, Deng H, Siddique N, Pascuzzi RT, et al. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003; 4: 162–6
  • Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. European Journal of Neurology. 2005; 12: 921–38
  • Mandich, P, Jacopini, G, Di Maria, E, Sabbadini, G, Abbruzzese, G, Chimirri, F, , et al. Predictive testing for Huntington's disease: 10 years' experience in two Italian centres. Ital J Neurol Sci. 1998;19:68–74. Erratum in: Ital J Neurol Sci. 1998;19:149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.